Cited by 75Viral Infectious Diseases and Gene Expression in InsectsMonoclonal and Polyclonal Antibodies ResearchTransgenic Plants and Applications

An efficient and targeted gene integration system for high-level antibody expression

Huang, Ying, Li, Yan, Wang, Yu Gang, Gu, Xin, Wang, Yan, Shen, Bei Fen·2007·Journal of Immunological Methods

Abstract

Random integration linking genomic amplification has been used to generate desired cell lines for stable and high-level expressing recombinant antibodies. But this technique is laborious, and the expression level is unpredictable due to position effects. Here, we have constructed a cell-vector system for high-level antibody expression using an FRT/FLP strategy to overcome position effects. The key is to target the FRT sequence to chromosomal locations where there is a high rate of transcription and gene amplification, and the amplified genes can be maintained. To screen desired loci with high transcriptional activity and amplifiable capacity, dual weakened markers (selectable galactosidase and amplifiable dihydrofolate reductase, DHFR) and the FRT sequence were synchronously cloned into a plasmid. After transfection of a Chinese hamster ovary host cell line with this plasmid, we selected 20 candidate cell lines from 721 individual clones. An antibody gene-targeting vector carrying an FRT-fused hygromycin gene was constructed to target antibody genes into the chromosomal FRT site by FLP recombinase. Three out of 20 cell lines can be used as host cells for site-specific recombination. By using southern blot and fluorescence in situ hybridization (FISH), a candidate engineered cell line, number 37, was chosen. It contains a single FRT-tagged locus in its genome. FISH analysis indicated that the antibody genes were all located at the original FRT-tagged locus in the genome of the…

Integrity signals

Registry

Crossref · 10.1016/j.jim.2007.01.022

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RMCE technology had good success in increasing the success rate and reducing timelines for generation of stable industrial-grade CHO cell lines stably expressing monoclonal antibodies.

    “This technology had good success in increasing the success rate and reducing timelines for the generation of stable industrial-grade CHO cell lines stably expressing monoclonal antibodies (Kito et al., 2002;Huang et al., 2007;Zhang et al., 2015).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Huang et al., 2007

  • Several recombinases have been used for targeted site approaches, among which Cre/Lox and Flp/FRT were mostly utilized.

    “As first generation tools, several recombinases have been used for targeted site approaches, among which the Cre/Lox and the Flp/FRT were mostly utilized (Kito et al., 2002;Huang et al., 2007;Kim et al., 2012).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Huang et al., 2007

Cited by

Sorted by citations

Authors
Huang, Y., Li, Y., Wang, Y. G., Gu, X., Wang, Y., & Shen, B. F.
Affiliations
Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences (CN)
Corresponding author
Shen, Bei Fen
Venue
Journal of Immunological Methods
Publisher
Elsevier BV
Published
2007-04
Volume
322
Issue
1-2
Pages
28-39
ISSN
0022-1759 (ISSN-L)
OpenAlex
W1982609556
Cited by
75
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 4
FWCI
2.12
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Immunological Methods (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
Keywords
recombinant antibody production, gene amplification, position effect, CHO cells, dihydrofolate reductase, galactosidase, hygromycin, fluorescence in situ hybridization
MeSH terms
Animals, Antibodies, Cricetulus, DNA, Female, Gene Amplification, Genetic Engineering, Cricetinae, Plasmids, Recombinant Proteins, Transcription, Genetic, Gene Expression, CHO Cells, In Situ Hybridization, Fluorescence, Gene Targeting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review